Royal Bank of Canada’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Sell |
6,606
-353
| -5% | -$18K | ﹤0.01% | 4432 |
|
|
2025
Q1 | $312K | Sell |
6,959
-3,550
| -34% | -$159K | ﹤0.01% | 4024 |
|
|
2024
Q4 | $434K | Sell |
10,509
-16,707
| -61% | -$690K | ﹤0.01% | 3748 |
|
|
2024
Q3 | $1.06M | Buy |
27,216
+22,392
| +464% | +$874K | ﹤0.01% | 3116 |
|
|
2024
Q2 | $165K | Buy |
4,824
+2,528
| +110% | +$86.5K | ﹤0.01% | 4529 |
|
|
2024
Q1 | $58K | Sell |
2,296
-5,551
| -71% | -$140K | ﹤0.01% | 5028 |
|
|
2023
Q4 | $232K | Buy |
7,847
+4,357
| +125% | +$129K | ﹤0.01% | 4456 |
|
|
2023
Q3 | $110K | Buy |
3,490
+1,639
| +89% | +$51.7K | ﹤0.01% | 4842 |
|
|
2023
Q2 | $48K | Buy |
1,851
+530
| +40% | +$13.7K | ﹤0.01% | 5354 |
|
|
2023
Q1 | $32K | Sell |
1,321
-1,413
| -52% | -$34.2K | ﹤0.01% | 5456 |
|
|
2022
Q4 | $53K | Buy |
2,734
+2,387
| +688% | +$46.3K | ﹤0.01% | 5372 |
|
|
2022
Q3 | $7K | Buy |
347
+139
| +67% | +$2.8K | ﹤0.01% | 6106 |
|
|
2022
Q2 | $4K | Sell |
208
-131
| -39% | -$2.52K | ﹤0.01% | 6265 |
|
|
2022
Q1 | $8K | Sell |
339
-657
| -66% | -$15.5K | ﹤0.01% | 6571 |
|
|
2021
Q4 | $15K | Buy |
996
+695
| +231% | +$10.5K | ﹤0.01% | 6381 |
|
|
2021
Q3 | $6K | Sell |
301
-299
| -50% | -$5.96K | ﹤0.01% | 6557 |
|
|
2021
Q2 | $10K | Buy |
600
+430
| +253% | +$7.17K | ﹤0.01% | 6367 |
|
|
2021
Q1 | $3K | Buy |
+170
| New | +$3K | ﹤0.01% | 6659 |
|
|
2020
Q4 | – | Sell |
-14
| Closed | – | – | 6603 |
|
|
2020
Q3 | $0 | Buy |
14
+1
| +8% | – | ﹤0.01% | 6256 |
|
|
2020
Q2 | $0 | Sell |
13
-254
| -95% | – | ﹤0.01% | 6236 |
|
|
2020
Q1 | $4K | Buy |
267
+188
| +238% | +$2.82K | ﹤0.01% | 5612 |
|
|
2019
Q4 | $2K | Sell |
79
-20
| -20% | -$506 | ﹤0.01% | 5954 |
|
|
2019
Q3 | $1K | Buy |
+99
| New | +$1K | ﹤0.01% | 5801 |
|